CADL: Candel Therapeutics, Inc. Stock

by  •  • Comments Off on CADL: Candel Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 396.53
Enterprise Value ($M) 394.88
Book Value ($M) -15.26
Book Value / Share -0.47
Price / Book -25.99
NCAV ($M) -18.69
NCAV / Share -0.58
Price / NCAV -21.22

Profitability (mra)
Return on Invested Capital (ROIC) -68.14
Return on Assets (ROA) -1.27
Return on Equity (ROE) -4.10

Liquidity (mrq)
Quick Ratio 1.18
Current Ratio 1.18

Balance Sheet (mrq) ($M)
Current Assets 18.09
Assets 21.52
Liabilities 36.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Northpond Ventures, LP
9 days ago 13G Baker Bros. Advisors Lp
02-07 13G Fmr Llc
02-07 13G/A CVI Investments, Inc.

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-25 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT P
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 427,318 1,512,475 28.25
2025-02-20 1,452,439 4,879,858 29.76
2025-02-19 577,276 2,313,413 24.95
2025-02-18 545,016 1,625,492 33.53

(click for more detail)

Similar Companies
BCAB – BioAtla, Inc. BHST – BioHarvest Sciences Inc.
BTMD – biote Corp. CARM – Carisma Therapeutics, Inc.
CGTX – Cognition Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io